STM91-01Homo sapiens (Human)Cancer cell line
Also known as: STM9101, STM-91-01
No AI-generated summary available for this cell line.
Basic Information
| Database ID | CVCL_8000 |
|---|---|
| Species | Homo sapiens (Human) |
| Tissue Source | Lung[UBERON:UBERON_0002048] |
Donor Information
| Age Category | Pediatric |
|---|---|
| Sex | Male |
Disease Information
| Disease | Rhabdoid tumor |
|---|---|
| Lineage | Kidney |
| Subtype | Rhabdoid Cancer |
| OncoTree Code | MRT |
DepMap Information
| Source Type | Academic lab |
|---|---|
| Source ID | ACH-001200_source |
Known Sequence Variations
| Type | Gene/Protein | Description | Zygosity | Note | Source |
|---|---|---|---|---|---|
| Gene deletion | SMARCB1 | - | Homozygous | - | PubMed=11921280 |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Loading gene expression data...
Publications
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Sellers W.R.
Nature 569:503-508(2019).
Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.
Ogawa S.
Cancer Sci. 105:258-264(2014).
Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Saito T., Yamamoto H., Tamiya S., Iwamoto Y., Tsuneyoshi M.
Mod. Pathol. 19:820-831(2006).
Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines: differentiation-induction using 5-azacytidine.
Sugita K.
Cancer Sci. 94:1059-1065(2003).
Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex.
Yoshida S., Narita T., Taga T., Ohta S., Takeuchi Y.
J. Neurosci. Res. 69:642-652(2002).
Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
Gilles F.H., Sugita K., Abe S., Sako M., Hashizume K., Hayashi Y.
Genes Chromosomes Cancer 34:33-41(2002).
Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence.
Oshiro Y., Oda Y., Ohta S., Furue M., Tsuneyoshi M.
Mod. Pathol. 14:854-861(2001).
Cloning and characterization of a novel Rab-family gene, Rab36, within the region at 22q11.2 that is homozygously deleted in malignant rhabdoid tumors.
Nakamura Y., Inazawa J.
Biochem. Biophys. Res. Commun. 254:594-600(1999).
Gene expression of malignant rhabdoid tumor cell lines by reverse transcriptase-polymerase chain reaction.
Suzuki A., Ohta S., Shimada M.
Diagn. Mol. Pathol. 6:326-332(1997).
Narrowing the critical region for a rhabdoid tumor locus in 22q11.";
Bell C.J.
Genes Chromosomes Cancer 16:94-105(1996).